Zoetis Inc (NYSE:ZTS) – Stock analysts at Jefferies Group reduced their FY2017 earnings estimates for shares of Zoetis in a research note issued on Tuesday. Jefferies Group analyst J. Holford now expects that the company will earn $2.38 per share for the year, down from their prior estimate of $2.39. Jefferies Group has a “Buy” rating and a $89.00 price objective on the stock. Jefferies Group also issued estimates for Zoetis’ FY2019 earnings at $3.59 EPS, FY2020 earnings at $4.06 EPS and FY2021 earnings at $4.47 EPS.
Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.02. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same period last year, the business posted $0.52 earnings per share. The firm’s revenue for the quarter was up 8.5% on a year-over-year basis.
Several other brokerages have also weighed in on ZTS. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $86.00 target price on shares of Zoetis in a research report on Thursday. Zacks Investment Research lowered Zoetis from a “hold” rating to a “sell” rating and set a $83.00 target price on the stock. in a research report on Saturday, January 13th. Cantor Fitzgerald set a $85.00 target price on Zoetis and gave the stock a “buy” rating in a research report on Thursday, January 11th. BMO Capital Markets increased their target price on Zoetis to $78.00 and gave the stock a “market perform” rating in a research report on Tuesday, January 9th. Finally, Citigroup raised Zoetis from a “neutral” rating to a “buy” rating and set a $85.00 target price on the stock in a research report on Thursday, January 4th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $73.72.
Zoetis (NYSE:ZTS) opened at $76.62 on Thursday. Zoetis has a one year low of $52.00 and a one year high of $77.03. The stock has a market capitalization of $37,340.00, a price-to-earnings ratio of 40.33, a P/E/G ratio of 1.84 and a beta of 1.06. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80.
Several institutional investors and hedge funds have recently modified their holdings of the company. Cibc Bank USA acquired a new position in shares of Zoetis during the fourth quarter valued at $226,000. State of Alaska Department of Revenue increased its holdings in shares of Zoetis by 1.5% during the fourth quarter. State of Alaska Department of Revenue now owns 185,981 shares of the company’s stock valued at $13,396,000 after purchasing an additional 2,700 shares during the period. Acadian Asset Management LLC increased its holdings in shares of Zoetis by 111.3% during the fourth quarter. Acadian Asset Management LLC now owns 1,709,352 shares of the company’s stock valued at $123,143,000 after purchasing an additional 900,261 shares during the period. Westpac Banking Corp increased its holdings in shares of Zoetis by 5.4% during the fourth quarter. Westpac Banking Corp now owns 315,647 shares of the company’s stock valued at $22,739,000 after purchasing an additional 16,300 shares during the period. Finally, Schwab Charles Investment Management Inc. increased its holdings in shares of Zoetis by 6.8% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 1,745,887 shares of the company’s stock valued at $125,774,000 after purchasing an additional 111,513 shares during the period. 93.14% of the stock is currently owned by institutional investors.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 1st. Stockholders of record on Friday, January 19th will be issued a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.66%. This is a positive change from Zoetis’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Thursday, January 18th. Zoetis’s dividend payout ratio (DPR) is 22.11%.
COPYRIGHT VIOLATION WARNING: “FY2017 EPS Estimates for Zoetis Inc Cut by Jefferies Group (ZTS)” was originally reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://www.truebluetribune.com/2018/01/20/fy2017-eps-estimates-for-zoetis-inc-cut-by-jefferies-group-zts.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.